Troxerutin: Difference between revisions
No edit summary |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| | | Verifiedfields = changed | ||
| verifiedrevid = | | verifiedrevid = 447983598 | ||
| IUPAC_name = | | IUPAC_name = 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-4-oxo-4''H''-chromen-3-yl 6-''O''-(6-deoxy-β-<small>D</small>-mannopyranosyl)-β-<small>D</small>-glucopyranoside | ||
| image = | | image = Troxerutin.png | ||
<!--Clinical data--> | <!--Clinical data--> | ||
| tradename = | | tradename = | ||
| Drugs.com = {{drugs.com|international|troxerutin}} | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | ||
| pregnancy_US = <!-- A / B / C / D / X --> | | pregnancy_US = <!-- A / B / C / D / X --> | ||
Line 15: | Line 16: | ||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | ||
| legal_status = | | legal_status = | ||
| routes_of_administration = | | routes_of_administration = | ||
<!--Pharmacokinetic data--> | <!--Pharmacokinetic data--> | ||
Line 22: | Line 23: | ||
| metabolism = | | metabolism = | ||
| elimination_half-life = | | elimination_half-life = | ||
| excretion = | | excretion = | ||
<!--Identifiers--> | <!--Identifiers--> | ||
| CAS_number_Ref = {{cascite| | | CAS_number_Ref = {{cascite|changed|??}} | ||
| CAS_number = | | CAS_number = 7085-55-4 | ||
| ATC_prefix = C05 | | ATC_prefix = C05 | ||
| ATC_suffix = | | ATC_suffix = CA04 | ||
| PubChem = | | PubChem = 9896814 | ||
| ChEMBL_Ref = {{ebicite|changed|EBI}} | |||
| ChEMBL = 2103946 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | ||
| DrugBank = | | DrugBank = | ||
| UNII_Ref = {{fdacite|correct|FDA}} | | UNII_Ref = {{fdacite|correct|FDA}} | ||
| UNII = | | UNII = 7Y4N11PXO8 | ||
<!--Chemical data--> | <!--Chemical data--> | ||
| C= | | C=33 | H=42 | O=19 | ||
| molecular_weight = | | molecular_weight = 742.67518 g/mol | ||
| synonyms = | | ExactMass = 742.23203 u | ||
| synonyms = Hydroxyethylrutoside (HER)<br>Pherarutin<br>Trihydroxyethylrutin<br>3',4',7-Tris[O-(2-hydroxyethyl)]rutin | |||
}} | }} | ||
__NOTOC__ | |||
{{ | {{SI}} | ||
{{CMG}} | |||
''' | ==Overview== | ||
'''Troxerutin''' is a [[flavonol]], a type of flavonoid. It is more accurately a [[hydroxyethylrutoside]]. It can be isolated from ''[[Sophora japonica]]'', the Japanese pagoda tree | |||
*It is used as a [[vasoprotective]]. | |||
*Troxerutin has been shown in mice to reverse CNS insulin resistance and reduce [[reactive oxygen species]] induced by a high-cholesterol diet. | |||
== References == | == References == | ||
{{reflist|2}} | {{reflist|2}} | ||
{{Vasoprotectives}} | {{Vasoprotectives}} | ||
[[Category:Phenol ethers]] | [[Category:Phenol ethers]] | ||
[[Category:Cardiovascular Drugs]][[Category:Drugs]] | [[Category:Cardiovascular Drugs]] | ||
[[Category:Drugs]] | |||
Latest revision as of 14:32, 13 April 2015
Clinical data | |
---|---|
Synonyms | Hydroxyethylrutoside (HER) Pherarutin Trihydroxyethylrutin 3',4',7-Tris[O-(2-hydroxyethyl)]rutin |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C33H42O19 |
Molar mass | 742.67518 g/mol |
(what is this?) (verify) |
WikiDoc Resources for Troxerutin |
Articles |
---|
Most recent articles on Troxerutin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Troxerutin at Clinical Trials.gov Clinical Trials on Troxerutin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Troxerutin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Troxerutin Discussion groups on Troxerutin Patient Handouts on Troxerutin Directions to Hospitals Treating Troxerutin Risk calculators and risk factors for Troxerutin
|
Healthcare Provider Resources |
Causes & Risk Factors for Troxerutin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Troxerutin is a flavonol, a type of flavonoid. It is more accurately a hydroxyethylrutoside. It can be isolated from Sophora japonica, the Japanese pagoda tree
- It is used as a vasoprotective.
- Troxerutin has been shown in mice to reverse CNS insulin resistance and reduce reactive oxygen species induced by a high-cholesterol diet.
References
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Phenol ethers
- Cardiovascular Drugs
- Drugs